Beijing, January 25 (Xinhua) according to Hong Kong’s Wen Wei Po, after Pfizer, an American pharmaceutical company, said it would reduce the supply of new vaccines to the European Union, AstraZeneca, a British pharmaceutical company, also said recently that the first batch of vaccines to be supplied to the European Union would be reduced by 60% due to the production capacity of the factory, causing dissatisfaction from many countries and even threatening lawsuits from Italy.
In January and September local time, the new crown vaccination center in Cannes Film palace began to open in Cannes, France. The picture shows medical staff vaccinating at the Xinguan vaccination center in the movie palace.
The European Union is expected to approve the emergency use of the new crown vaccine jointly developed by AstraZeneca and Oxford University on the 29th of this month. However, an AstraZeneca spokesman said that the initial vaccine production will be lower than expected due to the decline of production capacity of a Belgian factory.
The source pointed out that AstraZeneca originally planned to supply 80 million doses of new crown vaccine to the European Union by the end of March. It is expected to ship the vaccine on February 15, but now it has greatly reduced 60% to 31 million doses.
The EU has previously ordered 300 million doses of the vaccine and has the right to order an additional 100 million doses. Italy originally planned to receive 8 million doses of Oxford vaccine in the first quarter of this year, but now the delivery volume is expected to be only 3.4 million doses.
Italian Prime Minister Condoleezza Conte criticized the practice as unacceptable, saying that delaying the supply of vaccines is tantamount to violating the agreement and causing serious damage to Italy and other countries, and he also threatened to take legal action.
Austria originally expected to get 2 million doses of AstraZeneca vaccine in the first quarter, but now it can only get 600000 doses. Austrian health minister ansobel called this “very, very bad news” and “totally unacceptable”. Irish Prime Minister Martin said: “this will disrupt our plan.”.
Vaccination schedules in European countries have been frustrated by Pfizer’s cuts. In a statement on the 15th, Pfizer said the impact on vaccine shipments was caused by the company’s adjustment of production process to increase vaccine production.
Several EU countries said the situation was “unacceptable” and warned that it “reduces the credibility of vaccination programs.”. Under the pressure of the European Union, Pfizer finally issued a statement again, saying that it would resume the normal supply of vaccines as planned from the 25th.